News

Video

Shorter Radiation Courses May Improve Breast Reconstruction Outcomes

Fact checked by:

Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.

Shorter courses of radiation therapy may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi, chair of the Department of Radiation Oncology at Emory University School of Medicine.

At the 42nd Annual Miami Breast Cancer Conference, CURE spoke with Jagsi to discuss new research on optimizing radiation therapy for patients undergoing breast reconstruction. Traditionally, concerns have existed that shorter radiation courses could lead to more side effects or complications, according to Jagsi. However, recent studies indicate that these condensed treatment schedules maintain efficacy and may even enhance patient experience, particularly in younger individuals.

Findings from the recently published FABREC and RT CHARM trials support this approach, offering a more efficient treatment option.

Jagsi also highlighted findings from the Mastectomy Reconstruction Outcomes Consortium, which compared reconstruction techniques in the context of radiation therapy. The study found that tissue-based (autologous) reconstruction is less adversely affected by radiation than implant-based reconstruction, leading to better outcomes and higher patient satisfaction when feasible.

Beyond reconstruction, Jagsi addressed advancements in selecting patients who may safely omit radiation therapy after breast-conserving surgery. Research into breast cancer biology and genomic markers has helped identify subgroups with a low absolute risk of recurrence. While radiation significantly reduces recurrence risk, older patients with early-stage, estrogen receptor-positive tumors and favorable tumor biology may be candidates for omission.

Jagsi emphasized the importance of individualized treatment planning, balancing clinical data with patient values to optimize outcomes.

Transcript:

So one of the things that was really interesting that was presented just recently in the medical literature was looking at comparing shorter and longer courses of radiation treatment. And the concern when we shorten radiation courses is that we might actually increase the side effects of radiation, maybe have more complications from breast reconstruction. But what we actually found is that shortening the course of radiation therapy doesn't appear to make it worse, and might even in some patients, in one study, in younger patients, might even improve the experience with breast reconstruction.

So one thing is to potentially consider these shorter courses of radiation treatment, which also just have benefits to patients, because as much as patients love us as their physicians, I've never met one who wants to see me more often or for more treatments than she needs to have. So if we can give a more efficient approach to radiation, we very much would like to do that, and we now, thanks to two important trials just published in the last year, the FABREC trial and the RT CHARM trial, these landmark studies have given patients a really wonderful option to try to optimize their outcomes.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
CURE spoke with Andy Guinigundo to discuss the role that biomarkers play for patients with breast cancer.
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.